![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | EXP | | 6480464 | ethylene dichloride results in increased expression of B3GNT7 mRNA | CTD | PMID:28960355 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of B3GNT7 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1310580 | 6480464 | Ethinyl Estradiol results in increased expression of B3GNT7 mRNA | CTD | PMID:17557909 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of B3GNT7 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1310580 | 6480464 | Tetrachlorodibenzodioxin affects the expression of B3GNT7 mRNA | CTD | PMID:34747641 | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased methylation of B3GNT7 promoter | CTD | PMID:33297965 | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of B3GNT7 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | ISO | RGD:1310580 | 6480464 | Propylthiouracil results in increased expression of B3GNT7 mRNA | CTD | PMID:24780913 | acetamide | increases expression | ISO | RGD:1310580 | 6480464 | acetamide results in increased expression of B3GNT7 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | ISO | RGD:1321569 | 6480464 | Acrylamide results in increased expression of B3GNT7 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases methylation | ISO | RGD:1321569 | 6480464 | Aflatoxin B1 results in decreased methylation of B3GNT7 polyA tail | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | RGD:1321569 | 6480464 | Tretinoin results in increased expression of B3GNT7 mRNA | CTD | PMID:23830798 | aristolochic acid | increases expression | ISO | RGD:1321569 | 6480464 | aristolochic acid I results in increased expression of B3GNT7 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of B3GNT7 exon | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | RGD:1321569 | 6480464 | Benzo(a)pyrene results in decreased methylation of B3GNT7 3' UTR, Benzo(a)pyrene results in decreased methylation of B3GNT7 promoter | CTD | PMID:27901495 | bisphenol A | decreases methylation | ISO | RGD:1321569 | 6480464 | bisphenol A results in decreased methylation of B3GNT7 gene | CTD | PMID:31601247 | cefaloridine | decreases expression | ISO | RGD:1310580 | 6480464 | Cephaloridine results in decreased expression of B3GNT7 mRNA | CTD | PMID:18500788 | cisplatin | decreases expression | ISO | RGD:1321569 | 6480464 | Cisplatin results in decreased expression of B3GNT7 mRNA | CTD | PMID:27594783 | copper atom | multiple interactions | ISO | RGD:1321569 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of B3GNT7 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1321569 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of B3GNT7 mRNA | CTD | PMID:20971185 | dextran sulfate | multiple interactions | EXP | | 6480464 | Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of B3GNT7 protein] | CTD | PMID:32272095 | dextran sulfate | decreases expression | EXP | | 6480464 | Dextran Sulfate results in decreased expression of B3GNT7 protein | CTD | PMID:32272095 | dibutyl phthalate | increases expression | ISO | RGD:1310580 | 6480464 | Dibutyl Phthalate results in increased expression of B3GNT7 mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | ISO | RGD:1321569 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:1321569 | 6480464 | Doxorubicin results in decreased expression of B3GNT7 mRNA | CTD | PMID:29803840 | entinostat | increases expression | ISO | RGD:1321569 | 6480464 | entinostat results in increased expression of B3GNT7 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | RGD:1321569 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GNT7 mRNA | CTD | PMID:27188386 | flusilazole | affects expression | EXP | | 6480464 | flusilazole affects the expression of B3GNT7 mRNA | CTD | PMID:21195148 | formaldehyde | increases expression | ISO | RGD:1321569 | 6480464 | Formaldehyde results in increased expression of B3GNT7 mRNA | CTD | PMID:28937961 | gentamycin | affects expression | ISO | RGD:1310580 | 6480464 | Gentamicins affects the expression of B3GNT7 mRNA | CTD | PMID:33387578 | glycidol | increases expression | ISO | RGD:1310580 | 6480464 | glycidol results in increased expression of B3GNT7 mRNA | CTD | PMID:24915197 | hexaconazole | affects expression | EXP | | 6480464 | hexaconazole affects the expression of B3GNT7 mRNA | CTD | PMID:21195148 | nitrofen | decreases expression | ISO | RGD:1310580 | 6480464 | nitrofen results in decreased expression of B3GNT7 mRNA | CTD | PMID:26720608 | panobinostat | multiple interactions | ISO | RGD:1321569 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GNT7 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | RGD:1321569 | 6480464 | panobinostat results in increased expression of B3GNT7 mRNA | CTD | PMID:26272509 | paracetamol | decreases expression | ISO | RGD:1310580 | 6480464 | Acetaminophen results in decreased expression of B3GNT7 mRNA | CTD | PMID:33387578 | SB 431542 | multiple interactions | ISO | RGD:1321569 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | RGD:1321569 | 6480464 | sodium arsenite results in increased expression of B3GNT7 mRNA | CTD | PMID:34032870 | thioacetamide | increases expression | ISO | RGD:1310580 | 6480464 | Thioacetamide results in increased expression of B3GNT7 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | RGD:1310580 | 6480464 | titanium dioxide results in increased expression of B3GNT7 mRNA | CTD | PMID:30012374 | triadimefon | affects expression | EXP | | 6480464 | triadimefon affects the expression of B3GNT7 mRNA | CTD | PMID:21195148 | valproic acid | affects expression | ISO | RGD:1321569 | 6480464 | Valproic Acid affects the expression of B3GNT7 mRNA | CTD | PMID:25979313 | valproic acid | increases methylation | ISO | RGD:1321569 | 6480464 | Valproic Acid results in increased methylation of B3GNT7 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:1321569 | 6480464 | Valproic Acid results in increased expression of B3GNT7 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | RGD:1321569 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GNT7 mRNA | CTD | PMID:27188386 | |